Clinical Trial Update: HRS 4642 Injection Combined With AG Versus Placebo Combined With AG Therapy in First-Line Advanced or Metastatic Pancreatic Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating HRS 4642 injection plus AG therapy versus placebo plus AG therapy as first-line treatment for KRAS G12D-mutant advanced or metastatic p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• AG Therapy (AG Therapy)
• HRS 4642 Injection (HRS-4642)

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: KRAS G12D-Mutant Advanced or Metastatic Pancreatic Cancer in the First-line Setting | Phase 3 | Status: NOT_YET_RECRUITING